A Review of the Scientific Literature As It Pertains to Gulf War Illnesses

Volume 2: Pyridostigmine Bromide

Beatrice A. Golomb

ResearchPublished 1999

The United States and its allies in the Persian Gulf War (PGW) knew that Iraq had used nerve agents and chemical weapons in its previous conflicts and so took steps to protect their troops. Pyridostigmine bromide (PB) was distributed as a pretreatment that would enhance the effectiveness of postexposure treatments in the event that the nerve agent soman was used. This report examines the role that PB played in the ongoing chronic health problems documented in PGW veterans. After careful examination of the known effects of PB on the central and peripheral nervous systems, the author finds the evidence consistent with a possible role for PB as a contributor to the health complaints of some PGW veterans and calls for immediate attention in the form of additional investigation to clarify the role of PB.

Order a Print Copy

Format
Paperback
Page count
399 pages
List Price
$30.00
Buy link
Add to Cart

Topics

Document Details

  • Copyright: RAND Corporation
  • Availability: Available
  • Year: 1999
  • Print Format: Paperback
  • Paperback Pages: 399
  • Paperback Price: $30.00
  • Paperback ISBN/EAN: 978-0-8330-2677-4
  • DOI: https://doi.org/10.7249/MR1018.2
  • Document Number: MR-1018/2-OSD

Citation

RAND Style Manual
Golomb, Beatrice A., A Review of the Scientific Literature As It Pertains to Gulf War Illnesses: Volume 2: Pyridostigmine Bromide, RAND Corporation, MR-1018/2-OSD, 1999. As of September 10, 2024: https://www.rand.org/pubs/monograph_reports/MR1018z2.html
Chicago Manual of Style
Golomb, Beatrice A., A Review of the Scientific Literature As It Pertains to Gulf War Illnesses: Volume 2: Pyridostigmine Bromide. Santa Monica, CA: RAND Corporation, 1999. https://www.rand.org/pubs/monograph_reports/MR1018z2.html. Also available in print form.
BibTeX RIS

Research conducted by

This research was sponsored by the RAND National Security Research Division and RAND Health.

This publication is part of the RAND monograph report series. The monograph report was a product of RAND from 1993 to 2003. RAND monograph reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.